IDiyas

For the Inventor, By the Inventor

Vienna, Austria

Otto Schwarz

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 1,040(Granted Patents)


Company Filing History:

goldMedal14 out of 36 
 
Immuno Aktiengesellschaft Fur Chemisch-medizinische Produkte
 patents
silverMedal2 out of 83 
 
Immuno Aktiengesellschaft
 patents
bronzeMedal1 out of 1 
 
Immuno Aktiengesellschaft Fur Chemisch-medizinisch Produkte
 patent

Years Active: 1979-1995

Loading Chart...
17 patents (USPTO):
1. 5410022 - Method of producing a factor VIII preparation (1995-04-25),
2. 5234685 - Method of determining incompatibility-reaction-causing substances in (1993-08-10),
3. 5122373 - Immunoglobulin-G-containing fraction (1992-06-16),
4. 4904641 - Method of inactivating reproducible filterable pathogens in blood plasma (1990-02-27),
5. 4886758 - Method of determining incompatibility-reaction-causing substances in (1989-12-12),
6. 4814435 - Method of producing a factor VIII (AHF) containing fraction (1989-03-21),
7. 4687664 - Method of inactivating reproducible pathogens (1987-08-18),
8. 4640834 - Method of inactivating reproducible filterable pathogens in blood (1987-02-03),
9. 4522751 - Method for producing a preparation containing factor VIII (AHF) (1985-06-11),
10. 4414976 - Tissue adhesive (1983-11-15),
11. 4404131 - Method of producing a factor-VIII(AHF)-high-concentrate (1983-09-13),
12. 4395396 - Blood-coagulation-promoting preparation based on human proteins and a (1983-07-26),
13. 4377572 - Tissue adhesive (1983-03-22),
14. 4362567 - Tissue adhesive (1982-12-07),
15. 4298598 - Tissue adhesive (1981-11-03),

Title: Inventor Otto Schwarz: A Pioneer in Blood Product Safety

Introduction

Otto Schwarz, a notable inventor based in Vienna, Austria, has made significant contributions to the field of medicine through his innovative ideas and inventions. With a total of 17 patents to his name, he has established himself as a leader in developing safer and more effective blood products.

Latest Patents

Among his latest patents, Schwarz has developed a method for producing virus-safe and highly purified factor VIII. This invention addresses a critical need in hemophilia treatment, ensuring that patients receive blood products that are free from viral contamination. Additionally, he has created a method for determining and inactivating incompatibility-reaction-causing substances in blood products. This method involves treating a fraction obtained from human or animal blood with pancreatic enzymes bound to water-insoluble carrier material, which is crucial for improving the safety of blood transfusions.

Career Highlights

Throughout his career, Otto Schwarz has worked with respected organizations such as Immuno Aktiengesellschaft für Chemisch-medizinische Produkte and Immuno Aktiengesellschaft. His experience in these companies has allowed him to focus on enhancing the safety and efficacy of therapeutic blood products.

Collaborations

Schwarz has collaborated with other brilliant minds in the medical field, including Yendra Linnau and Johann J. Eibl. These partnerships have contributed to his successful inventions and emphasized the importance of teamwork in advancing medical technology.

Conclusion

In summary, Otto Schwarz stands out as a remarkable inventor whose work has had a profound impact on blood product safety and effectiveness. His dedication to innovation has not only advanced medical practices but has also improved the lives of countless individuals relying on safe blood transfusions and therapies. His legacy of invention and collaboration continues to inspire future generations of researchers and inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…